论文部分内容阅读
肝纤维化是慢性肝病的重要病理改变,肝纤维化的发展与肝病的进展及预后有密切关系。将病变终止于肝纤维化阶段甚至逆转至正常是治疗慢性肝病的关键。目前国内外用于临床有效抗肝纤维化药物不多。笔者于1996～1999年在使用肝复肽联合复方丹参在抗肝纤维化方面显示一定疗效,现将
Liver fibrosis is an important pathological change of chronic liver disease. The development of hepatic fibrosis is closely related to the progress and prognosis of liver disease. The key to treating chronic liver disease is to terminate the lesion in liver fibrosis even back to normal. At present, there are not many drugs for clinical effective anti-liver fibrosis at home and abroad. The author in 1996 to 1999 in the use of liver compound peptide combined with Salvia in the anti-liver fibrosis has shown some effect, now